Harvard Bioscience Sets Incentive Plan for Top Executives

Harvard Bioscience (HBIO) has provided an announcement.

Harvard Bioscience, Inc.’s Compensation Committee has recently greenlit the 2024 annual cash incentive plan, setting up a substantial performance-based earning potential for their CEO and CFO. Each executive has a target award pegged as a percentage of their base salary, with the chance to earn up to 150% of that target by meeting specific corporate financial goals.

For an in-depth examination of HBIO stock, go to TipRanks’ Stock Analysis page.